Home
Inbox
Search
Event
Long-Term Consequences of Clinically Important Deterioration in Patients with Chronic Obstructive Pulmonary Disease Treated with Twice-Daily Inhaled Corticosteroid/Long-Acting β2-Agonist Therapy: Results from the TORCH Study [Board No. P1346]
Location:
Board no. P1346
Session Type:
Thematic Poster Session
Monday
May
21
11:15 AM
1:00 PM
Bookmark
Add to Agenda
Speaker(s)/Author(s)
Necdet Gunsoy
PhD
GSK
Afisi Segun. Ismaila
PhD
GlaxoSmithKline
Andrew Briggs
DPhil
ICON
Victoria Paly
MHS
ICON
Nancy Risebrough
BA
ICON
Maurice T. Driessen
PhD
GSK
Ian Naya
BSc
GSK
View Abstract
Long-Term Consequences of Clinically Important Deterioration in Patients with Chronic Obstructive Pulmonary Disease Treated with Twice-Daily Inhaled Corticosteroid/Long-Acting β2-Agonist Therapy: Results from the TORCH Study
Parent Sessions
B33 - COPD: MAINTENANCE THERAPY
05-21-2018
9:15 AM - 4:15 PM
Home
Inbox
Search